New Insulin Combinations: For Whom? Why? When? The Rationale, Effectiveness and Safety of Fixed Ratio, Single Injection Regimens Combining a Short-Acting GLP-1 RA and Basal Insulin:

New Insulin Combinations: For Whom? Why? When? The Rationale, Effectiveness and Safety of Fixed Ratio, Single Injection Regimens Combining a Short-Acting GLP-1 RA and Basal Insulin:


Published

June 28, 2017

Created by

CMEducation Resources symposium

Related Presenters

Juan P. Frias, MD, FACE

Juan P. Frias, MD, FACE

Endocrinology, Diabetes and Metabolism
Clinical Assistant Professor of Medicine
University of California, San Diego
President and Principal Investigator
National Research Institute